AnalystsKostas BiliourisKostas Biliouris's Stock Forecasts
AnalystsKostas Biliouris
Sectors:
Industries:
Analyst Ranking
Bottom 5%
#4726 out of 4927 analysts
Average Return
-22.79%
Win Rate
22%11 out of 49
Risk vs Reward
Poor
Good
Kostas Biliouris's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alnylam Pharmaceuticals IncALNY | +74.37% | $154.39 | $269.21 | 2024-03-27 - 2025-03-26 | Buy |
Alnylam Pharmaceuticals IncALNY | +60.24% | $169.06 | $270.90 | 2023-10-10 - 2024-10-09 | Buy |
Verve Therapeutics IncVERV | +57.31% | $12.65 | $19.90 | 2022-06-17 - 2023-06-16 | Buy |
Centessa Pharmaceuticals PLCCNTA | +52.80% | $4.28 | $6.54 | 2022-08-11 - 2023-08-10 | Buy |
Legend Biotech CorpLEGN | +51.57% | $46.23 | $70.07 | 2022-06-17 - 2023-06-16 | Buy |
Kostas Biliouris Analyst Color
Get additional color on Kostas Biliouris's coverage of popular stocks
Kostas Biliouris's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verve Therapeutics IncVERV | 3 | Hold | $13.50 | +19.68% | Downgrades | 6 days ago |
Alnylam Pharmaceuticals IncALNY | 5 | Buy | $360.00 | +11.78% | Maintains | 9 days ago |
Sarepta Therapeutics IncSRPT | 5 | Hold | $70.00 | +295.26% | Downgrades | 17 days ago |
Rocket Pharmaceuticals IncRCKT | 2 | Buy | $8.00 | +208.88% | Maintains | a month ago |
Avidity Biosciences IncRNA | 1 | Buy | $72.00 | +152.99% | Initiates Coverage On | 4 months ago |
Dyne Therapeutics IncDYN | 1 | Buy | $50.00 | +476.04% | Initiates Coverage On | 4 months ago |
Silence Therapeutics PLCSLN | 2 | Buy | $25.00 | +322.30% | Maintains | 4 months ago |
Ionis Pharmaceuticals IncIONS | 2 | Hold | $45.00 | +12.67% | Maintains | 4 months ago |
Intellia Therapeutics IncNTLA | 6 | Buy | $50.00 | +406.07% | Maintains | 6 months ago |
Precision Biosciences IncDTIL | 3 | Buy | $34.00 | +723.24% | Upgrades | 6 months ago |
Centessa Pharmaceuticals PLCCNTA | 6 | Buy | $35.00 | +165.76% | Maintains | 10 months ago |
Metagenomi IncMGX | 2 | Buy | $17.00 | +1,022.11% | Maintains | a year ago |
4d Molecular Therapeutics IncFDMT | 4 | Buy | $40.00 | +863.86% | Maintains | a year ago |
Legend Biotech CorpLEGN | 3 | Buy | $90.00 | +148.00% | Maintains | a year ago |
Korro Bio IncKRRO | 3 | Buy | $120.00 | N/A | Maintains | a year ago |
Beam Therapeutics IncBEAM | 3 | Buy | $57.00 | N/A | Maintains | a year ago |
Bridgebio Pharma IncBBIO | 1 | Hold | $37.00 | N/A | Initiates Coverage On | a year ago |
Biomarin Pharmaceutical IncBMRN | 4 | Buy | $100.00 | N/A | Maintains | 2 years ago |
Prime Medicine IncPRME | 1 | Buy | $19.00 | N/A | Initiates Coverage On | 2 years ago |
Lenz Therapeutics IncLENZ | 2 | Hold | $7.00 | N/A | Downgrades | 2 years ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $98.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.